• No se han encontrado resultados

WellCare’s New Jersey

N/A
N/A
Protected

Academic year: 2023

Share "WellCare’s New Jersey "

Copied!
3
0
0

Texto completo

(1)

NJ023800_PRO_LTR_ENG Internal Approved 02112015 63816

© WellCare 2014 NJ_10_15

09/13/2018

Dear Provider:

At the September 13, 2018 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be made to the WellCare’s New Jersey Medicaid Preferred Drug List (PDL), effective 12/02/2018. Please carefully review these changes.

Key

UPPER CASE = Brand Name Drugs QL = Quantity Limit Lower case italics = Generic Drugs ST = Step Therapy PDL = Preferred Drug List AL = Age Limit PA = Prior Authorization YOA = Years of Age SC = Safety Concerns LU = Low Utilization PC = Pharmacoeconomic Considerations DD = Discontinued Drug GA = Generic Available

Effective date of change: 12/02/2018

Drug Name Therapeutic Class Change PDL Alternative (if applicable) ADDITIONS TO THE PDL

ARISTADA INITIO vial

Antipsychotic Added to the PDL PA & QL:

QL :2.4mL /365 days

ARNUITY ELLIPTA 50mcg powder

Antiasthmatic/Bron chodilator

Added to the PDL QL:31/31 days BIKTARVY 50-200-

25mg tablet

Antivirals Added to the PDL

HEPATITIS A vaccine

Vaccines Added to the PDL w/ AL:

AL: Members 19 YOA & older:

Members 18 YOA

UPDATE

WellCare’s New Jersey

Preferred Drug List

(2)

& younger:

Product/Service not covered for patient age;

Excluded for patient age;

Minimum patient age of 19 YOA HUMIRA PEN-

CD/UC/HS STARTER 80mg/0.8ml kit

Analgesics-Anti- Inflammatory

Added to the PDL w/ PA

HUMIRA PEN- PS/UV STARTER 80mg/0.8ml & 40 mg/0.4ml kit

Analgesics-Anti- Inflammatory

Added to the PDL w/ PA

ZENPEP 10000 unit capsules

Digestive Enzymes Added to the PDL

UTILIZATION MANAGEMENT CHANGES clindamycin

phosphate 1%

solution

Dermatological agents

QL added:

QL: 120 ml / 31 days

SPINOSAD 0.9%

suspension

Dermatological agents

ST added

REMOVALS FROM THE PDL DRYSOL 20%

solution

Dermatological agents

Removed from the PDL/PC

HYPERCARE solution 20%

external econazole 1% cream Dermatological

agents

Removed from the PDL/PC

clotrimazole 1%

cream external, ketoconazole 2%

cream external FORADIL aerolizer

capsule 12mcg for inhalation

Antiasthmatic and Bronchodilator agents

Removed from the PDL/DD

STRIVERDI

RESPIMAT aerosol solution 2.5

mcg/act inhalation, VENTOLIN HFA inhalation aerosol

(3)

solution 108 (90 base) mcg/act lidocaine 5%

ointment

Dermatological agents

Removed from the PDL/PC

lidocaine hcl solution 4 % external lidocaine hcl external 2% gel naproxen oral

suspension 125 mg/5mL

Analgesics-Anti- Inflammatory

Removed from the PDL/PC

ibuprofen oral suspension 100 mg/5mL tronvite 1mg tablet Multivitamins Removed from

the PDL/PC

DIALYVITE tablet, rena-vite tablet, triphrocaps 1mg

If you have questions, WellCare’s Pharmacy Help Desk is available to assist providers 1- 888-453-2534.

Thank you for your care of WellCare’s New Jersey members.

Sincerely,

WellCare Health Plans, Inc.

Referencias

Documento similar

De acuerdo con el Sistema Informático de Notificación de Accidentes de Trabajo, Incidentes Peligrosos y Enfermedades Ocupacionales – SAT, en el mes de febrero de 2022 se registraron